Tamoxifen for breast cancer prevention is not routinely used

Cancer prevention is built around screening. In screening, the hope is to catch cancer at an earlier stage than it would be found otherwise and increase options for treatment and chances of cure. In some cases, screening prevents cancer — for example, when a precancerous polyp is removed from the colon during colonoscopy — but generally it is aimed at early detection.

What if instead we could prevent cancer from developing altogether?

I met Mrs. TR in clinic for the first time recently. At 72, she looked great. As she bounced from the examining table to the chair next to me, she told me how busy her life was. Though she retired from nursing years ago, she helps out in her church every day of the week except Saturday and has 10 grandchildren and great-grandchildren she spends her evenings with.

Mrs. TR was referred to me by a breast surgeon after her previous primary care doctor passed away. She didn’t have a history of breast cancer herself, but had a strong family history. One of her sisters died of metastatic breast cancer, diagnosed at age 58; a second sister passed at age 70 of an unknown cancer. In reviewing her record, I was impressed at how aggressive her screening regimen was. She received a mammogram and a breast MRI every year and was evaluated by a breast surgeon twice per year. “I’m really scared about getting cancer and want to do everything to make sure I don’t get it,” she explained.

When she said this, my mind immediately jumped to tamoxifen. Unlike screening, which can only detect breast cancer earlier, tamoxifen can actually prevent breast cancer from developing. Used for years for the treatment of breast cancer, tamoxifen has now been tested and approved by the FDA for the breast cancer prevention (called chemoprevention). Remarkably, studies show that in women at increased risk tamoxifen and its cousin raloxifene prevent 50 percent of invasive breast cancers. Half.

Mrs. TR didn’t recall ever being counseled about tamoxifen before. Unlike screening, breast cancer chemoprevention has not received widespread attention and usage. If you were to ask a room full of women whether we have a pill that prevents breast cancer, I suspect many would say no; they would be surprised to learn that for well over a decade we have had not one but two medications that taken daily safely cut a woman’s risk of developing breast cancer by half. On the other side of equation, primary care doctors have been gun shy about recommending these medications, largely because they don’t have much experience prescribing them (this, of course, is a circular argument), despite the fact that counseling women at high risk of breast cancer about tamoxifen is supported by the United States Preventive Services Task Force (USPSTF).

The benefit of tamoxifen varies with a woman’s risk of the disease — the greater the risk of breast cancer, the greater the benefit. Similar to the Framingham risk calculator for heart disease, scientists have created “risk calculators” that allow doctors to estimate a woman’s risk of developing breast cancer. To calculate Mrs. TR’s risk, I went to the  the National Cancer Institute website. After inputting information about her age, race, family history, and menstrual history I found out that she has a 4.8% risk of breast cancer over the next 5 years and a lifetime risk of 11.7%.

I told Mrs. TR that she had a 1 in 10 chance of developing breast cancer in her lifetime and that tamoxifen would reduce this risk to 1 in 20. Then I explained the risks of the medication. Because it blocks the effects of estrogen, tamoxifen can cause symptoms of menopause such as hot flashes. More rarely, tamoxifen increases the risk of blood clots similar to oral contraceptives and the risk of uterine cancer. These risks are not small, I noted, and must be balanced against the potential benefits of therapy.

Despite her assertion that she wanted to do everything possible to prevent breast cancer, Mrs. TR balked at tamoxifen. The idea of taking a medication, especially one that had potential for serious side effects, for a disease she might never get was untenable to her. Looking at her other medications — a statin, two blood pressure-lowering medications, and three vitamins — I was caught off guard by this reasoning. Dyslipidemia isn’t itself a life-threatening disease; she was taking a cholesterol-lowering medication every day to reduce her risk of heart disease. Statins furthermore are not without side effects; though rare, they have been associated with serious medical conditions such as rhabdomyolysis and liver failure. Likewise, though elevated blood pressures may itself sometimes cause health problems, doctors treat hypertension primarily to reduce cardiovascular disease. And vitamins, except for vitamin D, are largely unproven in her age group, yet they too are a pill one must take every day.

In the end, Mrs. TR agreed to be referred to our high-risk breast cancer clinic for further counseling about chemoprevention. It is certainly not my intent to get her on tamoxifen therapy. It is drug not without cost and harm, and in the end it is her choice to make. However, given her keen desire to prevent breast cancer, I was struck that she would be willing to bear the risk, cost, and inconvenience of cholesterol-lowering medications and antihypertensives to prevent a disease she is at no higher risk of than most women her age and yet not be interested in a medication to prevent breast cancer, a disease she is at increased risk of. Moreover, she is pursuing an aggressive screening regimen for breast cancer, one that is not well proven, carries its own risks, and that at best will identify breast cancer earlier than it would be found otherwise.

Mrs. TR is not alone. Support for tamoxifen in breast cancer prevention is bafflingly low amongst both doctors and patients, though it is routinely used for treatment. There is a pill out there to prevent breast cancer — it’s just that most women are finding it hard to swallow.

Shantanu Nundy is an internal medicine physician and author of Stay Healthy At Every Age: What Your Doctor Wants You to Know.

Submit a guest post and be heard.

Comments are moderated before they are published. Please read the comment policy.

  • Brenda

    I think any male doctor who is “baffled” by the low adoption of tamoxifen by high-risk women (and it usually is male doctors who are confounded) should take a testosterone-suppressing pill for 6 months, and then re-evaluate his perspective. It’s not rocket science: the side effects are very unpleasant, and not nearly as uncommon as this article insinuates.

  • A.N. Mousse

    There are many good reasons not to take tamoxifen. The side effects of it are often intolerable – and the reduction in risk not enough in many women for those patients to be able to justify the miserable side effects. At 72, Mrs. TR, may very well go the rest of her natural life with a slow-growing breast cancer (or none at all) – and die of something altogether different. Her circumstances, and her particular risk for contracting breast cancer at her age, are best addressed through a breast cancer specialist – to whom you referred her.

    But, the suggestion that all us here wimmen are abein’ stoopid for not subjecting ourselves to the hateful side effects of a drug that often only reduces the risk of getting breast cancer – or in my case a recurrence – by a small amount (my risk of recurrence was reduced by only 3%) is a failure to understand the whole health and life of a woman. Certainly, there are patients for whom the risk reduction is substantial, and the side effects, therefore, more justifiable.

    However, the idea that you hint at – at prophylactically prescribing tamoxifen as if it were some statin drug – is ridiculous. Breast cancer today is over diagnosed and over treated because science has not yet been able to identify which cancers (I’m speaking specifically of DCIS) will become invasive and which will not.

    Each patient must be educated about her personal risk and be allowed to decide for herself what she wants to do. No finger-wagging from patronizing physicians or “breast heath educators”.

    Mrs. TR could go on tamoxifen, or one of the other hormone-suppressing therapies, and have a completely miserable quality of life for the time she has left. It’s up to her to decide what she wants to live with.

    Pharma wants all us stoopid wimmen to take their drugs – more profits for them – but not necessarily a better life for the patient.

  • http://secondbasedispatch.com Jackie Fox

    I’ve been on Tamoxifen since having a mastectomy two years ago and am lucky to not experience side effects. I discussed the risks and benefits with my oncologist and family doctor, and am taking a daily low-dose aspirin to counteract potential clotting. I think my family doctor gave me every blood clot test known to mankind, so I feel pretty good about that.

    I agree this is a highly personal choice and just as with any other cancer treatment, each woman has to weigh the risks and gauge her own comfort level.

    This was a very interesting post–thank you.